Relationship between biofilm formation of Pseudomonas aeruginosa and susceptibility to rifaximin and ofloxacin.

IF 0.7 4区 医学 Q4 PHARMACOLOGY & PHARMACY
Jenan Atiyah Ghafil, Susan Fawzi Khadhem Al-Sudani, Bashar Mohammed Salih Ibrahim, Ali Muhmed Alshahrani, Ayaid Khadem Zgair
{"title":"Relationship between biofilm formation of Pseudomonas aeruginosa and susceptibility to rifaximin and ofloxacin.","authors":"Jenan Atiyah Ghafil, Susan Fawzi Khadhem Al-Sudani, Bashar Mohammed Salih Ibrahim, Ali Muhmed Alshahrani, Ayaid Khadem Zgair","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Pseudomonas aeruginosa is responsible for many infectious diseases related to antibiotic resistance. Biofilm formation may help bacteria to pass the treatment with antibiotics and overcome the immune system. Here, the relationship between antibiotics (rifaximin and ofloxacin) susceptibility and biofilm formation was evaluated. Ten isolates of P. aeruginosa were isolated from 110 urine specimens obtained from urinary tract infections (UTIs) patients. The spectrophotometric method was used to measure biofilm formation on polystyrene microtiter plates. Inhibitory zone onto agar plates was used to measure the antibiotic susceptibility of rifaximin and ofloxacin against the ten P. aeruginosa (Pa1, Pa2, Pa3, Pa15, Pa18, Pa22, Pa23, Pa25, Pa26 and Pa27) isolates. The highest inhibition zones were seen against Pa 25 and Pa 3 respectively, while the lowest inhibition zones of rifaximin were seen against Pa3, Pa23 and Pa25. Moreover, the lowest inhibition zones of both antibiotics were seen in the cases of Pa1 and Pa27 respectively. The maximum biofilm formation was seen in the case of Pa3, while Pa27 produced the lowest biofilm. The study showed no relationship between biofilm formation and susceptibility to rifaximin and ofloxacin (P>0.05).</p>","PeriodicalId":19971,"journal":{"name":"Pakistan journal of pharmaceutical sciences","volume":"37 6","pages":"1609-1614"},"PeriodicalIF":0.7000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pakistan journal of pharmaceutical sciences","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Pseudomonas aeruginosa is responsible for many infectious diseases related to antibiotic resistance. Biofilm formation may help bacteria to pass the treatment with antibiotics and overcome the immune system. Here, the relationship between antibiotics (rifaximin and ofloxacin) susceptibility and biofilm formation was evaluated. Ten isolates of P. aeruginosa were isolated from 110 urine specimens obtained from urinary tract infections (UTIs) patients. The spectrophotometric method was used to measure biofilm formation on polystyrene microtiter plates. Inhibitory zone onto agar plates was used to measure the antibiotic susceptibility of rifaximin and ofloxacin against the ten P. aeruginosa (Pa1, Pa2, Pa3, Pa15, Pa18, Pa22, Pa23, Pa25, Pa26 and Pa27) isolates. The highest inhibition zones were seen against Pa 25 and Pa 3 respectively, while the lowest inhibition zones of rifaximin were seen against Pa3, Pa23 and Pa25. Moreover, the lowest inhibition zones of both antibiotics were seen in the cases of Pa1 and Pa27 respectively. The maximum biofilm formation was seen in the case of Pa3, while Pa27 produced the lowest biofilm. The study showed no relationship between biofilm formation and susceptibility to rifaximin and ofloxacin (P>0.05).

求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.40
自引率
12.50%
发文量
211
审稿时长
4.5 months
期刊介绍: Pakistan Journal of Pharmaceutical Sciences (PJPS) is a peer reviewed multi-disciplinary pharmaceutical sciences journal. The PJPS had its origin in 1988 from the Faculty of Pharmacy, University of Karachi as a biannual journal, frequency converted as quarterly in 2005, and now PJPS is being published as bi-monthly from January 2013. PJPS covers Biological, Pharmaceutical and Medicinal Research (Drug Delivery, Pharmacy Management, Molecular Biology, Biochemical, Pharmacology, Pharmacokinetics, Phytochemical, Bio-analytical, Therapeutics, Biotechnology and research on nano particles.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信